Literature DB >> 17379852

Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension.

Anastasia Anthi1, Roberto F Machado, Maria L Jison, Angelo M Taveira-Dasilva, Lewis J Rubin, Lori Hunter, Christian J Hunter, Wynona Coles, James Nichols, Nilo A Avila, Vandana Sachdev, Clara C Chen, Mark T Gladwin.   

Abstract

RATIONALE: Although pulmonary hypertension (PH) is a common complication of sickle cell disease (SCD) associated with high mortality, there exist few data characterizing hemodynamics and cardiopulmonary function in this population.
OBJECTIVES: To characterize hemodynamics and cardiopulmonary function in patients with SCD with and without PH.
METHODS: Patients with SCD with PH (n = 26) were compared with control subjects with SCD but without PH (n = 17), matched for age, hemoglobin levels, and fetal hemoglobin levels.
MEASUREMENTS AND MAIN RESULTS: Upon catheterization, 54% of the patients with PH had pulmonary arterial hypertension, and 46% had pulmonary venous hypertension. When compared with control subjects, patients with PH exhibited lower six-minute-walk distance (435 +/- 31 vs. 320 +/- 20 m, p = 0.002) and oxygen consumption (50 +/- 3% vs. 41 +/- 2% of predicted, p = 0.02), and also had mild restrictive lung disease and more perfusion abnormalities on radionuclide lung scans. The six-minute-walk distance in this population inversely correlated with tricuspid regurgitant jet velocity (r = -0.55, p < 0.001), and mean pulmonary artery pressure (r = -0.57, p < 0.001), and directly correlated with maximal oxygen consumption (r = 0.49, p = 0.004), even after adjustment for hemoglobin, supporting an independent contribution of increasing pulmonary artery pressures to loss of exercise capacity.
CONCLUSIONS: Patients with SCD-associated PH have both pulmonary arterial and venous PH associated with severe limitations in exercise capacity, likely compounded by interstitial lung fibrosis and severe anemia. These data support the use of the six-minute-walk distance as an index of PH and cardiopulmonary function in patients with SCD.

Entities:  

Mesh:

Year:  2007        PMID: 17379852      PMCID: PMC2176091          DOI: 10.1164/rccm.200610-1498OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  41 in total

1.  ATS statement on six-minute walk test.

Authors:  Dina Brooks; Sherra Solway; William J Gibbons
Journal:  Am J Respir Crit Care Med       Date:  2003-05-01       Impact factor: 21.405

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

Review 3.  ATS/ACCP Statement on cardiopulmonary exercise testing.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2003-01-15       Impact factor: 21.405

4.  Hermansky-Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies.

Authors:  Nilo A Avila; Mark Brantly; Ahalya Premkumar; Marjan Huizing; Andrew Dwyer; William A Gahl
Journal:  AJR Am J Roentgenol       Date:  2002-10       Impact factor: 3.959

5.  [Hemolytic anemia due to aortic valve regurgitation after mitral valve replacement].

Authors:  H Iwaki; S Kuraoka; S Tatebe
Journal:  Kyobu Geka       Date:  2003-02

6.  Causes of death in sickle cell disease: an autopsy study.

Authors:  Elizabeth A Manci; Donald E Culberson; Yih-Ming Yang; Todd M Gardner; Randall Powell; Johnson Haynes; Arvind K Shah; Vipul N Mankad
Journal:  Br J Haematol       Date:  2003-10       Impact factor: 6.998

7.  Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival.

Authors:  Oswaldo Castro; Mohammed Hoque; Bernice D Brown
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

8.  Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Mario P Stylianou; Carolyn J Hedin; Arnold S Kristof; Nilo A Avila; Antoinette Rabel; William D Travis; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2003-09-04       Impact factor: 21.405

9.  Pulmonary function in primary pulmonary hypertension.

Authors:  Xing-Guo Sun; James E Hansen; Ronald J Oudiz; Karlman Wasserman
Journal:  J Am Coll Cardiol       Date:  2003-03-19       Impact factor: 24.094

10.  Impaired oxygenation and increased hemolysis after cardiopulmonary bypass in patients with glucose-6-phosphate dehydrogenase deficiency.

Authors:  Rabin Gerrah; Yaron Shargal; Amir Elami
Journal:  Ann Thorac Surg       Date:  2003-08       Impact factor: 4.330

View more
  84 in total

Review 1.  Vasculopathy and pulmonary hypertension in sickle cell disease.

Authors:  Karin P Potoka; Mark T Gladwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-14       Impact factor: 5.464

2.  The impact of recurrent acute chest syndrome on the lung function of young adults with sickle cell disease.

Authors:  Jennifer M Knight-Madden; Terrence S Forrester; Norma A Lewis; Anne Greenough
Journal:  Lung       Date:  2010-07-20       Impact factor: 2.584

3.  Segmentation and quantification of pulmonary artery for noninvasive CT assessment of sickle cell secondary pulmonary hypertension.

Authors:  Marius George Linguraru; John A Pura; Robert L Van Uitert; Nisha Mukherjee; Ronald M Summers; Caterina Minniti; Mark T Gladwin; Gregory Kato; Roberto F Machado; Bradford J Wood
Journal:  Med Phys       Date:  2010-04       Impact factor: 4.071

Review 4.  Balancing exercise risk and benefits: lessons learned from sickle cell trait and sickle cell anemia.

Authors:  Robert I Liem
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

5.  Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.

Authors:  Robyn J Barst; Kamal K Mubarak; Roberto F Machado; Kenneth I Ataga; Raymond L Benza; Oswaldo Castro; Robert Naeije; Namita Sood; Paul S Swerdlow; Mariana Hildesheim; Mark T Gladwin
Journal:  Br J Haematol       Date:  2010-02-17       Impact factor: 6.998

6.  CT and image processing non-invasive indicators of sickle cell secondary pulmonary hypertension.

Authors:  Marius George Linguraru; Babak J Orandi; Robert L Van Uitert; Nisha Mukherjee; Ronald M Summers; Mark T Gladwin; Roberto F Machado; Bradford J Wood
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2008

7.  Abnormal Ventilation-Perfusion Scan Is Associated with Pulmonary Hypertension in Sickle Cell Adults.

Authors:  Alem Mehari; Norris Igbineweka; Darlene Allen; Jim Nichols; Swee Lay Thein; Nargues A Weir
Journal:  J Nucl Med       Date:  2018-06-07       Impact factor: 10.057

8.  Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.

Authors:  Matthew M Hsieh; Elizabeth M Kang; Courtney D Fitzhugh; M Beth Link; Charles D Bolan; Roger Kurlander; Richard W Childs; Griffin P Rodgers; Jonathan D Powell; John F Tisdale
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

9.  Longitudinal analysis of pulmonary function in adults with sickle cell disease.

Authors:  Joshua J Field; Jeffrey Glassberg; Annette Gilmore; Joanna Howard; Sameer Patankar; Yan Yan; Sally C Davies; Michael R Debaun; Robert C Strunk
Journal:  Am J Hematol       Date:  2008-07       Impact factor: 10.047

10.  Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.

Authors:  Sergei Nekhai; Min Xu; Altreisha Foster; Ishmael Kasvosve; Sharmin Diaz; Roberto F Machado; Oswaldo L Castro; Gregory J Kato; James G Taylor; Victor R Gordeuk
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.